Phillipe Moreau (Philippe Moreau, P Moreau)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 77

Top Venues

British journal of haematology

Blood cancer journal

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

CHU de Nantes

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHU de Nantes

France

PU-PH Hématologe Clinique :: Hématologie

CRCINA

France

Membre :: Equipe 11 Oncogénomique intégrative de la genèse et de la progression du myélome multiple

Université de Nantes

France

Professeur de 1ère classe :: Hématologie

Université de Nantes

France

Professeur d'Hématologie Clinique :: Hématologie

CHU de Nantes

France

Chef de Service :: Hématologie Clinique

Université de Nantes

France

Professeur de Classe Exceptionnelle :: Hémotologie

CHU de Nantes

France

Délégué à la Recherche Clinique :: Hématologie

CHU de Nantes

France

Responsable auprès de l'INCa de l'Unité Labellisée Phase Précoce :: Hématologie

Publications

Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
B Ferment, J Lambert, D Caillot, I Lafon, L Karlin, A Lazareth, Cyrille Touzeau, Xavier Leleu, N Moya, S Harel, Aurore Perrot, Pierre Bories, L Vincent, S Lamure, Mohamad Mohty, F Malard, S Manier, I Yakoub-Agha, J-M Schiano De Colella, G Brisou, A Talbot, O Decaux, R Houot, S Le Gouill, N Bigot, T Facon, Jill Corre, Phillipe Moreau, Bertrand Arnulf, null null
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry. British journal of haematology (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology 99 (3) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Aurore Perrot, Murielle Roussel, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Cyrille Touzeau, Thierry Facon, Clara Mariette, Jean-Marc Schiano, Julie Gay, Lydiane Mordier, Dana Ranta, Amandine Huguet, Soraya Wuillème, Thomas Dejoie, Laure Devlamynck, Jill Corre, Hervé Avet-Loiseau, Phillipe Moreau, Michel Attal
Twice-weekly induction with ixazomib-lenalidomide-dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant-eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014-03. British journal of haematology (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Yannick Le Bris, Simon Bouzy, Benoît Tessoulin, Thomas Gastinne, Viviane Dubruille, Cyrille Touzeau, Béatrice Mahé, Nicolas Blin, Anne Lok, Sophie Vantyghem, Clara Sortais, Chloé Antier, Phillipe Moreau, Emmanuel Scotet, Marie C Béné, Patrice Chevallier
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide. American journal of hematology (2024)
Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Michele Cavo, Meletios- Athanasios Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Paul Gerard Richardson, Phillipe Moreau
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial. European journal of haematology 113 (2) (2024)
Paula Rodriguez Otero, Niels W C J van de Donk, Kodandaram Pillarisetti, Ingrid Cornax, Deeksha Vishwamitra, Kathleen Gray, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Tara Masterson, Christoph Heuck, Colleen Kane, Raluca Verona, Phillipe Moreau, Nizar J Bahlis, Ajai Chari
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood cancer journal 14 (1) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti, Albert Ortiol, Phillipe Moreau, Ian McFadden, Qing Xia, Mukta Arora, Meletios- Athanasios Dimopoulos
An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. Leukemia & lymphoma 65 (6) (2024)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Bénédicte Piron, Domitille Costes-Tertrais, Thomas Gastinne, Aude Marie Fourmont, Viviane Dubruille, Nicolas Blin, Phillipe Moreau, Cyrille Touzeau, Benoît Tessoulin
Quad-class exposed/refractory myeloma is associated with short survival. British journal of haematology (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Juan José Lahuerta, Irene Manrique, Julie A Rytlewski, Timothy Campbell, Christian C Kazanecki, Nathan Martin, Larry D Anderson, Jesus G Berdeja, Sagar Lonial, Noopur S Raje, Yi Lin, Phillipe Moreau, Jesús San F Miguel, Nikhil C Munshi, Shari Kaiser
Time-dependent prognostic value of serological and measurable residual disease assessments after idecabtagene vicleucel. Blood cancer discovery (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Alexander M Lesokhin, Richard LeBlanc, Meletios A Dimopoulos, Marcelo Capra, Carmelo Carlo-Stella, Lionel Karlin, Jean-Francois Castilloux, Peter Forsberg, Gurdeep Parmar, Axel Tosikyan, Ludek Pour, Vincent Ribrag, Rossella Ribolla, Al-Ola Abdallah, Nadia Le Roux, Liyan Dong, Helgi van de Velde, Laurent Mayrargue, Lucie Lépine, Sandrine Macé, Phillipe Moreau
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study. Cancer medicine (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, Murielle Roussel, Laure Devlamynck, Marie Odile Petillon, Martine Escoffre-Barbe, Ingrid Lafon, Thierry Facon, Xavier Leleu, Lionel Karlin, Aurore Perrot, Anne-Marie Stoppa, Bruno Royer, Carine Chaleteix, Mourad Tiab, Carla Araujo, Pascal Lenain, Margaret Macro, Karim Belhadj, Souhila Ikhlef, Cyrille Hulin, Herve Avet Loiseau, Michel Attal, Phillipe Moreau
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma. British journal of haematology (2023)
Noopur S Raje, Kenneth C Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P Hammond, Alexander M Lesokhin, Sagar Lonial, Heinz Ludwig, Phillipe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos-Manteca
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood cancer journal 13 (1) (2023)
Phillipe Moreau, Ajai Chari, Albert Ortiol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikandar Ailawadhi, Britta Besemer, Javier de la Rubia, Cristina Encinas, Maria-Victoria Mateos-Manteca, Hans J Salwender, Paula Rodriguez Otero, Cyrille Hulin, Lionel Karlin, Anna Sureda Balari, Joan Bargay, Lotfi Benboubker, Laura Rosinol, Stefano Tarantolo, Howard Terebelo, Shiyi Yang, Jianping Wang, Ivo Nnane, Ming Qi, Michele Kosh, Maria Delioukina, Hartmut Goldschmidt
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS. Blood cancer journal 13 (1) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Meletios- Athanasios Dimopoulos, Albert Ortiol, Hareth Nahi, Jesús San F Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Kenshi Suzuki, Torben Plesner, Sung Soo Yoon, Dina Ben Yehuda, Paul Gerard Richardson, Hartmut Goldschmidt, Donna Reece, Tahamtan Ahmadi, Xiang Qin, Wendy Garvin Mayo, Xue Gai, Jodi Carey, Robin Carson, Phillipe Moreau
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nicolas Lecornec, Marie-Pierre Castex, Yves Réguerre, Phillipe Moreau, Isabelle Marie, Loïc Garçon, Lydie Da Costa, Thierry Leblanc
Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: A retrospective study of the French DBA cohort. British journal of haematology 199 (2) (2022)
Ivan Spicka, Phillipe Moreau, Thomas G Martin, Thierry Facon, Gracia Martinez, Albert Ortiol, Youngil Koh, Andrew Lim, Gabor Mikala, Laura Rosiñol, Münci Yağci, Michele Cavo, Marie-Laure Risse, Gaëlle Asset, Sandrine Macé, Helgi van de Velde, Kwee Yong
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis. European journal of haematology 109 (5) (2022)
Meletios- Athanasios Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Phillipe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc-Steffen Raab, Paul Gerard Richardson, Mihaela Popa McKiver, Ying-Ming Jou, David Yao, Prianka Das, Jesús San F Miguel
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Meletios- Athanasios Dimopoulos, Phillipe Moreau, Bradley Augustson, Nelson Castro, Tomas Pika, Sosana Delimpasi, Javier De la Rubia, Angelo Maiolino, Tony Reiman, Joaquin Martinez-Lopez, Thomas Martin, Joseph R Mikhael, Kwee Yong, Marie-Laure Risse, Gaelle Asset, Sylvia Marion, Roman Hajek
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. American journal of hematology (2022)
Evangelos Terpos, Meletios- Athanasios Dimopoulos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Phillipe Moreau, Alessandra Pompa, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Katharine S Gries, John Fastenau, Kevin Liu, Jianming He, Tobias Kampfenkel, Yanping Qiu, Himal Amin, Robin Carson, Pieter Sonneveld
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial. American journal of hematology 97 (4) (2022)
Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H J van der Velden, Remco M Hoogenboezem, Bronno van der Holt, H Berna Beverloo, Erik T Valent, Michael Vermeulen, Francesca Gay, Annemiek Broijl, Herve Avet-Loiseau, Nikhil C Munshi, Pellegrino Musto, Phillipe Moreau, Sonja Zweegman, Niels W C J van de Donk, Pieter Sonneveld
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Thomas Chalopin, Nicolas Vallet, Olivier Theisen, Marlène Ochmann, Mourad Tiab, Pascal Godmer, Carole Barin, Olivier Hérault, Emmanuel Gyan, Steven Le Gouill, Hervé Avet-Loiseau, Lotfi Benboubker, Phillipe Moreau, Cyrille Touzeau
No survival improvement in patients with high-risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades. British journal of haematology 194 (3) (2021)
Sosana Delimpasi, Maria Victoria Mateos, Holger W Auner, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Hang Quach, Halyna Pylypenko, Roman Hájek, Xavier Leleu, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Reuben Benjamin, Mamta Krishnan Garg, Vadim Doronin, Yair Levy, Phillipe Moreau, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Paul Gerard Richardson, Sebastian Grosicki
Efficacy and Tolerability of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Standard Twice-Weekly Bortezomib and Dexamethasone in Previously Treated Multiple Myeloma with Renal Impairment: Subgroup Analysis from the BOSTON Study. American journal of hematology (2021)
Shambavi Richard, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryna Kriachok, Meletios- Athanasios Dimopoulos, Halyna Pylypenko, Holger W Auner, Xavier Leleu, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D Anderson, Nizar J Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Hua Chang, Yosef Landesman, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Sebastian Grosicki, Paul G Richardson
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk. American journal of hematology 96 (9) (2021)
Phillipe Moreau, Razi Ghori, Mohammed Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with carfilzomib and low-dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE-023 study. British journal of haematology 194 (1) (2021)
Heinz Ludwig, Jesús San-Miguel, Nikhil Munshi, Pieter Sonneveld, María-Victoria Mateos, Phillipe Moreau, Evangelos Terpos
Covid-19 vaccination in patients with multiple myeloma: Focus on immune response. American journal of hematology 96 (8) (2021)
Nizar J Bahlis, Rachid Baz, Simon J Harrison, Hang Quach, Shir Jing Ho, Annette Juul Vangsted, Torben Plesner, Phillipe Moreau, Simon D Gibbs, Sheryl Coppola, Xiaoqing Yang, Abdullah Al Masud, Jeremy A Ross, Orlando Bueno, Jonathan L Kaufman
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Schjesvold Fredrik, Sara Bringhen, Paul Gerard Richardson, Aurore Perrot, Xavier Leleu, Phillipe Moreau, Meletios- Athanasios Dimopoulos, Cyrille Hulin, Christina Tekle, Meredith C Foster, Elizabeth M Poole, Helgi van de Velde, Thierry Facon
Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. American journal of hematology 96 (11) (2021)
Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, Thomas Drumel, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Benoît Tessoulin, Maxime Jullien, Sophie Vantyghem, Phillipe Moreau, Steven Le Gouill, Marie Christine Bene, Patrice Chevallier
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant. British journal of haematology (2021)
Holger W Auner, Maria Gavriatopoulou, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Meletios- Athanasios Dimopoulos, Iryna Kriachok, Halyna Pylypenko, Xavier Leleu, Vadim Doronin, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D Anderson, Nizar J Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Paul G Richardson, Sebastian Grosicki
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. American journal of hematology 96 (6) (2021)
Laura Rosinol, Meral Beksac, Elena Zamagni, Niels W C J Van de Donk, Kenneth C Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios- Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria-Victoria Mateos-Manteca, Giampaolo Merlini, Mohamad Mohty, Phillipe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z Usmani, Karin Vanderkerken, David H Vesole, Anders Waage, Sonja Zweegman, Paul Gerard Richardson, Joan Bladé
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. British journal of haematology 194 (3) (2021)
Paul Gerard Richardson, Phillipe Moreau
Reply to G. R. Mohyuddin et al and A. Garfall et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, Thomas Drumel, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Benoît Tessoulin, Maxime Jullien, Sophie Vanthygem, Marie Christine Bene, Phillipe Moreau, Steven Le Gouill, Patrice Chevallier
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy. British journal of haematology (2021)
Jonathan L Kaufman, Cristina Gasparetto, Schjesvold Fredrik, Phillipe Moreau, Cyrille Touzeau, Thierry Facon, Lawrence H Boise, Yanwen Jiang, Xiaoqing Yang, Fengjiao Dunbar, Deeksha Vishwamitra, Stefanie Unger, Tammy Macartney, John Pesko, Yao Yu, Ahmed Hamed Salem, Jeremy A Ross, Wan-Jen Hong, Paulo C Maciag, James M Pauff, Shaji Kumar
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. American journal of hematology 96 (4) (2021)
Paul G Richardson, Schjesvold Fredrik, Katja Weisel, Phillipe Moreau, Larry D Anderson, Darrell White, Paula Rodriguez-Otero, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Meral Beksac, Albert Ortiol, Jindriska Lindsay, Anna Marina Liberati, Monica Galli, Pawel Robak, Alessandra Larocca, Munci Yagci, Filiz Vural, Abraham S Kanate, Ruiyun Jiang, Lara Grote, Teresa Peluso, Meletios- Athanasios Dimopoulos
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. European journal of haematology 108 (1) (2021)
Alessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi, Hervé Avet-Loiseau, Tamás Masszi, Luísa Viterbo, Ludek Pour, Peter Ganly, Michele Cavo, Christian Langer, Shaji K Kumar, S Vincent Rajkumar, Jonathan J Keats, Deborah Berg, Jianchang Lin, Bin Li, Sunita Badola, Lei Shen, Jacob Zhang, Dixie-Lee Esseltine, Katarina Luptakova, Helgi van de Velde, Paul G Richardson, Phillipe Moreau
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma. European journal of haematology 105 (1) (2020)
Pierre Peterlin, Joelle Gaschet, Thierry Guillaume, Alice Garnier, Marion Eveillard, Amandine Le Bourgeois, Michel Cherel, Camille Debord, Yannick Le Bris, Olivier Theisen, Catherine Godon, Béatrice Mahé, Viviane Dubruille, Soraya Wuilleme, Cyrille Touzeau, Thomas Gastinne, Nicolas Blin, Anne Lok, Benoît Tessoulin, Steven Le Gouill, Phillipe Moreau, Marie-C Béné, Patrice Chevallier
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia. Cancer medicine 10 (2) (2020)
Ajeeta B Dash, Jacob Zhang, Lei Shen, Bin Li, Deborah Berg, Jianchang Lin, Hervé Avet-Loiseau, Nizar J Bahlis, Phillipe Moreau, Paul G Richardson, Alessandra Di Bacco
Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activation. European journal of haematology 105 (3) (2020)
Phillipe Moreau, Keith A Stewart, Meletios Dimopoulos, David Siegel, Thierry Facon, James Berenson, Noopur Raje, Jesus G Berdeja, Robert Z Orlowski, Hui Yang, Haijun Ma, Zandra Klippel, Anita Zahlten-Kumeli, Khalid Mezzi, Karim Iskander, Maria-Victoria Mateos
Once-weekly (70 mg/m2 ) vs twice-weekly (56 mg/m2 ) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials. Cancer medicine 9 (9) (2020)
Maria-Victoria Mateos-Manteca, Robert Z Orlowski, Enrique María Ocio, Paula Rodríguez-Otero, Donna Reece, Phillipe Moreau, Nikhil Munshi, David E Avigan, David S Siegel, Razi Ghori, Mohammed Z H Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study. British journal of haematology 186 (5) (2019)
Torben Plesner, Hendrik-Tobias Arkenau, Francesca Gay, Monique C Minnema, Mario Boccadoro, Phillipe Moreau, Jamie Cavenagh, Aurore Perrot, Jacob P Laubach, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M Schecter, Paul Gerard Richardson
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. British journal of haematology 186 (3) (2019)
Eileen Mary Boyle, Xavier Leleu, Marie-Odile Petillon, Lionel Karlin, Chantal Doyen, Hélène Demarquette, Bruno Royer, Margaret Macro, Phillipe Moreau, Karel Fostier, Chretien Marie-Lorraine, Charles Zarnitsky, Aurore Perrot, Charles Herbaux, Stephanie Poulain, Salomon Manier, David Beauvais, Brian A Walker, Christopher P Wardell, Laure Vincent, Laurent Frenzel, Hélène Caillon, Schraen Susanna, Thomas Dejoie, Hervé Avet-Loiseau, Mohamad Mohty, Thierry Facon, null null
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial. British journal of haematology 187 (3) (2019)
Xavier Leleu, Tamas Masszi, Nizar J Bahlis, Luisa Viterbo, Bartrum Baker, Peter Gimsing, Vladimir Maisnar, Olga Samoilova, Laura Rosiñol, Christian Langer, Kevin Song, Tohru Izumi, Charles Cleeland, Deborah Berg, Huamao Mark Lin, Yanyan Zhu, Tomas Skacel, Phillipe Moreau, Paul G Richardson
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. American journal of hematology (2018)
Patricia Gomez-Bougie, Sophie Maiga, Benoît Tessoulin, Jessie Bourcier, Antoine Bonnet, Manuel S Rodriguez, Steven Le Gouill, Cyrille Touzeau, Phillipe Moreau, Catherine Pellat-Deceunynck, Martine Amiot
BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment. Blood 132 (25) (2018)
Robin Boutault, Pierre Peterlin, Marouane Boubaya, Katja Sockel, Patrice Chevallier, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Camille Debord, Catherine Godon, Yannick Le Bris, Olivier Theisen, Frank Kroschinsky, Phillipe Moreau, Marie C Béné, Uwe Platzbecker, Marion Eveillard
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients. British journal of haematology 183 (5) (2018)
Elsa Lestang, Pierre Peterlin, Yannick Le Bris, Viviane Dubruille, Jacques Delaunay, Catherine Godon, Olivier Theisen, Nicolas Blin, Beatrice Mahe, Thomas Gastinne, Alice Garnier, Cyrille Touzeau, Maud Voldoire, Marie C Bene, Steven Le Gouill, Noel Milpied, Mohamad Mohty, Phillipe Moreau, Thierry Guillaume, Patrice Chevallier
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era? European journal of haematology 99 (1) (2017)
Phillipe Moreau, Meletios A Dimopoulos, Paul G Richardson, David S Siegel, Michele Cavo, Paolo Corradini, Katja Weisel, Michel Delforge, Peter O'Gorman, Kevin Song, Christine Chen, Nizar Bahlis, Albert Oriol, Markus Hansson, Martin Kaiser, Pekka Anttila, Reinier Raymakers, Cristina Joao, Gordon Cook, Lars Sternas, Tsvetan Biyukov, Ana Slaughter, Kevin Hong, Jennifer Herring, Xin Yu, Mohamed Zaki, Jesus San-Miguel
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis. European journal of haematology 99 (3) (2017)
Shaji K Kumar, Phillipe Moreau, Parameswaran Hari, Maria-Victoria Mateos, Heinz Ludwig, Chaim Shustik, Tamas Masszi, Andrew Spencer, Roman Hájek, Kenneth Romeril, Irit Avivi, Anna M Liberati, Monique C Minnema, Hermann Einsele, Sagar Lonial, Deborah Berg, Jianchang Lin, Neeraj Gupta, Dixie-Lee Esseltine, Paul G Richardson
Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. British journal of haematology 178 (4) (2017)
Jacob P Laubach, Javid J Moslehi, Sanjeev A Francis, Jesús F San Miguel, Pieter Sonneveld, Robert Z Orlowski, Phillipe Moreau, Laura Rosiñol, Edward A Faber, Peter Voorhees, Maria-Victoria Mateos, Loreta Marquez, Huaibao Feng, Avinash Desai, Helgi van de Velde, Jennifer Elliott, Hongliang Shi, Edward Dow, Nishith Jobanputra, Dixie-Lee Esseltine, Liviu Niculescu, Kenneth C Anderson, Sagar Lonial, Paul G Richardson
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma. British journal of haematology 178 (4) (2017)
Jesús San F Miguel, Vania T M Hungria, Sung-Soo Yoon, Meral Beksac, Meletios- Athanasios Dimopoulos, Ashraf Elghandour, Wieslaw W Jedrzejczak, Andreas Guenther, Thanyaphong Na Nakorn, Noppadol Siritanaratkul, Robert L Schlossman, Jian Hou, Phillipe Moreau, Sagar Lonial, Jae-Hoon Lee, Hermann Einsele, Hans Salwender, Monika Sopala, Suman Redhu, Sofia Paul, Claudia Corrado, Paul G Richardson
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial. British journal of haematology 179 (1) (2017)
Phillipe Moreau, Edwin de Wit
Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions. British journal of haematology 179 (2) (2017)
Meletios- Athanasios Dimopoulos, Sagar Lonial, Darrell White, Phillipe Moreau, Antonio Palumbo, Jesús San F Miguel, Ofer Shpilberg, Kenneth Anderson, Sebastian Grosicki, Ivan Spicka, Adam Walter-Croneck, Hila Magen, Maria-Victoria Mateos, Andrew Belch, Donna Reece, Meral Beksac, Eric Bleickardt, Valerie Poulart, Jennifer Sheng, Oumar Sy, Jessica Katz, Anil Singhal, Paul Richardson
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth. British journal of haematology 178 (6) (2017)

Phillipe Moreau.css-eqlu8i{font-size:small;padding-left:4px;} (Philippe Moreau, P Moreau)

Publication Activity (10 Years)

Top Topics

Top Venues

Phillipe Moreau (Philippe Moreau, P Moreau)